Literature DB >> 9278642

Human immunodeficiency virus and lung cancer.

M T Alshafie1, B Donaldson, S F Oluwole.   

Abstract

BACKGROUND: The association of human immunodeficiency virus (HIV) infection with lung cancer remains unclear. The presence of multiple risk factors in patients with HIV infection makes it difficult to identify a direct cause-effect relationship.
METHODS: A retrospective study of patients with lung cancer who were diagnosed, treated and followed at Harlem Hospital Center, New York, between January 1990 and December 1994 was performed. Eleven HIV-seropositive and 116 HIV-indeterminate patients with histologically proven lung cancer were identified. The two groups were compared with regard to age, sex, race, predisposing factors, stage of presentation, histological type of the tumours and survival.
RESULTS: HIV-infected patients with lung cancer were predominantly male smokers who were significantly younger than the control HIV-indeterminate patients with lung cancer. Although adenocarcinoma was seen more frequently in the HIV-seropositive group, the difference was not statistically significant. Survival in HIV-infected patients was shorter than that in HIV-indeterminate patients, suggesting that the cancer may be more aggressive in HIV-infected patients or that the progression of immunoincompetence in these patients may influence survival.
CONCLUSION: A direct cause-effect relationship between lung cancer and HIV infection is difficult to establish in the presence of other risk factors, but the incidence of lung cancer may be increasing in HIV-infected men.

Entities:  

Mesh:

Year:  1997        PMID: 9278642

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  19 in total

1.  Long-term survival following metachronous intratumoral hemorrhage in an HIV-infected patient with lung cancer.

Authors:  Yusuke Okuma; Yukio Hosomi; Yusuke Takagi; Shingo Miyamoto; Tsuneo Shimokawa; Mari Iguchi; Tatsuru Okamura; Kuniaki Saito; Masahiko Shibuya
Journal:  Int J Clin Oncol       Date:  2010-05-11       Impact factor: 3.402

2.  Age at cancer diagnosis among persons with AIDS in the United States.

Authors:  Meredith S Shiels; Ruth M Pfeiffer; Eric A Engels
Journal:  Ann Intern Med       Date:  2010-10-05       Impact factor: 25.391

Review 3.  Lung cancer in HIV-infected patients in the combination antiretroviral treatment era.

Authors:  José Moltó; Teresa Moran; Guillem Sirera; Bonaventura Clotet
Journal:  Transl Lung Cancer Res       Date:  2015-12

Review 4.  Lung cancer in HIV Infection.

Authors:  Deepthi Mani; Missak Haigentz; David M Aboulafia
Journal:  Clin Lung Cancer       Date:  2011-07-29       Impact factor: 4.785

5.  Non-AIDS-Defining Malignancies in the HIV-Infected Population.

Authors:  Chia-Ching J Wang; Michael J Silverberg; Donald I Abrams
Journal:  Curr Infect Dis Rep       Date:  2014-06       Impact factor: 3.725

6.  Cancer treatment disparities in HIV-infected individuals in the United States.

Authors:  Gita Suneja; Meredith S Shiels; Rory Angulo; Glenn E Copeland; Lou Gonsalves; Anne M Hakenewerth; Kathryn E Macomber; Sharon K Melville; Eric A Engels
Journal:  J Clin Oncol       Date:  2014-06-30       Impact factor: 44.544

7.  Clinical characteristics of Japanese lung cancer patients with human immunodeficiency virus infection.

Authors:  Yusuke Okuma; Naoki Yanagisawa; Yusuke Takagi; Yukio Hosomi; Akihiko Suganuma; Akifumi Imamura; Mari Iguchi; Tatsuru Okamura; Atsushi Ajisawa; Masahiko Shibuya
Journal:  Int J Clin Oncol       Date:  2011-09-16       Impact factor: 3.402

Review 8.  Epidemic of lung cancer in patients with HIV infection.

Authors:  Tiffany A Winstone; S F Paul Man; Mark Hull; Julio S Montaner; Don D Sin
Journal:  Chest       Date:  2013-02-01       Impact factor: 9.410

Review 9.  Lung cancer in HIV infected patients: facts, questions and challenges.

Authors:  J Cadranel; D Garfield; A Lavolé; M Wislez; B Milleron; C Mayaud
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

10.  Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals.

Authors:  Gita Suneja; Meredith S Shiels; Sharon K Melville; Melanie A Williams; Ramesh Rengan; Eric A Engels
Journal:  AIDS       Date:  2013-01-28       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.